This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Jubilant Generics Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Mohan Chikmagalur Sadashivappa: Innovator in Pharmaceutical Chemistry
Introduction
Mohan Chikmagalur Sadashivappa is a notable inventor based in Mysore, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of angiotensin receptor blockers. His work has implications for the treatment of various cardiovascular conditions.
Latest Patents
Mohan holds a patent for the "Preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereof." This invention relates to a process for preparing angiotensin receptor blockers, specifically Losartan and its potassium salt, while minimizing azido impurities to less than 10 ppm. The process is designed to be simple, economical, and industrially efficient, making it a valuable advancement in pharmaceutical manufacturing.
Career Highlights
Mohan is currently associated with Jubilant Generics Limited, where he applies his expertise in pharmaceutical development. His innovative approach has led to advancements in drug formulation and production processes.
Collaborations
Mohan has collaborated with colleagues such as Saji Thomas and Rajendra Shekhawat, contributing to a dynamic team focused on pharmaceutical innovation.
Conclusion
Mohan Chikmagalur Sadashivappa's contributions to pharmaceutical chemistry exemplify the impact of innovation in healthcare. His work continues to influence the development of effective treatments for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile